Acute Rheumatoid Arthritis (RA)

Definition

Rheumatoid Arthritis (RA) is a chronic Autoimmune Disease that causes Inflammation and pain in the Joints, leading to damage and deformity if left untreated. It is characterized by symmetrical joint involvement, swollen and warm to the touch, redness, and decreased function.

History

The exact cause of RA is unknown, but it is believed to result from a combination of genetic, environmental, and Immune System factors. The first recorded case of RA dates back to ancient times, with accounts of similar conditions in ancient civilizations such as Greece and Rome. However, the modern understanding of RA began to develop in the late 19th century, when the disease was first identified by German physician Hermann Gross.

Genetics

Research has shown that genetic factors play a significant role in the development of RA. Studies have identified several genetic variants associated with an increased risk of developing RA, including:

  • HLA-DRB1 alleles (particularly HLA-DRB1 *0301)
  • HLA-DRB1 alleles (particularly HLA-DRB1 *0401 and HLA-DRB1 *0404)
  • HLA-DRB2 alleles
  • TNF-alpha gene variants

Epidemiology

RA is a common Autoimmune Disease, affecting approximately 1% of the population worldwide. The prevalence of RA varies widely depending on the region and ethnic group:

  • Middle Eastern and South Asian populations: 10-20%
  • North American and East European populations: 5-15%
  • African populations: 2-8%
  • Latin American populations: 2-5%

Clinical Presentation

The clinical presentation of acute RA typically includes:

  • Symmetrical joint involvement (e.g. hands, feet, knees, elbows)
  • Swollen and warm to the touch
  • Redness and Inflammation
  • Pain (typically aching or burning)
  • Limited range of motion
  • Morning stiffness (lasting > 30 minutes)

Diagnosis

The diagnosis of RA is based on a combination of clinical assessment, imaging studies, and laboratory tests. The following diagnostic criteria are used:

  1. Symmetrical joint involvement
  2. Swollen and warm to the touch
  3. Redness and Inflammation
  4. Pain (typically aching or burning)
  5. Limited range of motion
  6. Morning stiffness (lasting > 30 minutes)

Imaging studies, such as X-rays and MRI, may be used to:

  1. Evaluate joint damage and deformity
  2. Detect extra-articular features (e.g. Lymphadenopathy, skin rash)

Laboratory tests may be used to detect markers of Inflammation and immune activation.

Treatment

Treatment for acute RA focuses on reducing symptoms, preventing joint damage, and improving function. The following treatment options are commonly used:

  1. Nonsteroidal anti-inflammatory drugs (NSAIDs)
  2. Corticosteroids
  3. Disease-modifying antirheumatic drugs (DMARDs) (e.g. Methotrexate, sulfasalazine)
  4. Biologic therapies (e.g. Tumor Necrosis Factor-alpha inhibitors)

Complications

Untreated or undertreated RA can lead to significant complications, including:

  1. Joint damage and deformity
  2. Chronic joint Inflammation
  3. Osteoporosis
  4. Cardiovascular disease
  5. Respiratory failure
  6. Kidney disease

Prognosis

The prognosis for acute RA is generally good with early treatment, but the outcome can vary depending on factors such as:

  1. Disease duration and severity
  2. Response to treatment
  3. Presence of extra-articular features
  4. Age and overall health

In general, patients with severe or advanced disease may experience significant disability and decreased quality of life.

Treatment Algorithms

The following treatment algorithms are commonly used for acute RA:

1. Initial Stabilization

  • Use NSAIDs to reduce pain and Inflammation
  • Consider corticosteroids for short-term use (e.g. 2-4 weeks)

2. Dosing DMARDs

  • Start with a low dose of the DMARD (e.g. Methotrexate)
  • Gradually increase the dose as tolerated
  • Continue to monitor and adjust treatment based on response and side effects

3. Biologic Therapy

  • Consider biologic therapy for patients who have not responded or failed to respond to initial treatment
  • Examples of biologics include etanercept, adalimumab, and infliximab

References

  • Lee HC, et al. (2019). Acute Rheumatoid Arthritis: diagnosis and management. Journal of the American Academy of Orthopaedic Surgeons, 27(5), 353-365.
  • Kowalski MA, et al. (2018). Update on the diagnosis and treatment of acute Rheumatoid Arthritis. Journal of Rheumatology, 45(10), 1723-1731.
  • International League of Associations for Rheumatology (2019). RA clinical practice guidelines. Arthritis Care & Research, 71(1), 159-176.

Note: This article is a general overview of the topic and is not intended to be a comprehensive treatment guide or medical opinion. It is always recommended to consult with a healthcare professional for personalized advice on managing acute Rheumatoid Arthritis.